Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-14-000723
Filing Date
2014-04-22
Accepted
2014-04-22 16:50:11
Documents
1
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3332
  Complete submission text file 0001078782-14-000723.txt   4916
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Reporting) CIK: 0001542484 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35814 | Film No.: 14776712